These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 29927556)

  • 1. Role of Hypercoagulable State for Predictive Ovarian Malignancy in Women with a Pelvic Mass.
    Yanaranop M
    J Med Assoc Thai; 2017 Feb; 100 Suppl 1():S148-56. PubMed ID: 29927556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rajavithi-ovarian cancer predictive score (R-OPS): A new scoring system for predicting ovarian malignancy in women presenting with a pelvic mass.
    Yanaranop M; Tiyayon J; Siricharoenthai S; Nakrangsee S; Thinkhamrop B
    Gynecol Oncol; 2016 Jun; 141(3):479-484. PubMed ID: 26996662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the Risk of Ovarian Malignancy Algorithm Better Than Other Tests for Predicting Ovarian Malignancy in Women with Pelvic Masses?
    Yanaranop M; Anakrat V; Siricharoenthai S; Nakrangsee S; Thinkhamrop B
    Gynecol Obstet Invest; 2017; 82(1):47-53. PubMed ID: 27197526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian masses.
    Lenhard M; Stieber P; Hertlein L; Kirschenhofer A; Fürst S; Mayr D; Nagel D; Hofmann K; Krocker K; Burges A
    Clin Chem Lab Med; 2011 Sep; 49(12):2081-8. PubMed ID: 21923475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of the IOTA ADNEX model in preoperative discrimination of adnexal masses in a gynecological oncology center.
    Araujo KG; Jales RM; Pereira PN; Yoshida A; de Angelo Andrade L; Sarian LO; Derchain S
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):778-783. PubMed ID: 27194129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian malignancy risk stratification of the adnexal mass using a multivariate index assay.
    Bristow RE; Smith A; Zhang Z; Chan DW; Crutcher G; Fung ET; Munroe DG
    Gynecol Oncol; 2013 Feb; 128(2):252-9. PubMed ID: 23178277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a correlation between inflammatory markers and coagulation parameters in women with advanced ovarian endometriosis?
    Ding S; Lin Q; Zhu T; Li T; Zhu L; Wang J; Zhang X
    BMC Womens Health; 2019 Dec; 19(1):169. PubMed ID: 31888633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
    Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
    Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Accuracy and Optimal Cutoff Value of Serum HE4 to Predict Ovarian Cancer in Thai Women with Pelvic Masses.
    Yanaranop M; Tiyayon J; Nakrangsee S; Thinkhamrop B
    J Med Assoc Thai; 2016 Dec; 99(12):1263-71. PubMed ID: 29952496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in tumor markers, coagulation function and serum VEGF in patients with ovarian cancer and benign ovarian disease.
    Wang J; Zhu M; Zhou X; Wang T; Zhang J
    J BUON; 2020; 25(5):2287-2292. PubMed ID: 33277847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive values of serum tumour markers tetranectin, OVX1, CASA and CA125 in patients with a pelvic mass.
    Hogdall EV; Høgdall CK; Tingulstad S; Hagen B; Nustad K; Xu FJ; Bast RC; Jacobs IJ
    Int J Cancer; 2000 Nov; 89(6):519-23. PubMed ID: 11102897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approaches to the detection of ovarian cancer.
    Høgdall E
    Scand J Clin Lab Invest Suppl; 2016; 245():S49-53. PubMed ID: 27435369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation studies in women using combination type of oral contraceptives.
    Sharma S; Sharma M; Soni IJ; Gupta A; Jain R
    J Obstet Gynaecol India; 1983 Aug; 33(4):519-24. PubMed ID: 12339832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue Factor Pathway Inhibitor 2: A Novel Biomarker for Predicting Asymptomatic Venous Thromboembolism in Patients with Epithelial Ovarian Cancer.
    Yamanaka S; Miyake R; Yamada Y; Kawaguchi R; Ootake N; Myoba S; Kobayashi H
    Gynecol Obstet Invest; 2022; 87(2):133-140. PubMed ID: 35613543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses.
    Van Gorp T; Veldman J; Van Calster B; Cadron I; Leunen K; Amant F; Timmerman D; Vergote I
    Eur J Cancer; 2012 Jul; 48(11):1649-56. PubMed ID: 22226481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of the preoperative platelet count in the diagnosis of adnexal tumors.
    Watrowski R; Heinze G; Jäger C; Forster J; Zeillinger R
    Tumour Biol; 2016 Sep; 37(9):12079-12087. PubMed ID: 27207344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancer.
    Claussen C; Rausch AV; Lezius S; Amirkhosravi A; Davila M; Francis JL; Hisada YM; Mackman N; Bokemeyer C; Schmalfeldt B; Mahner S; Langer F
    Thromb Res; 2016 May; 141():39-48. PubMed ID: 26967531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative serum tetranectin, CA125 and menopausal status used as single markers in screening and in a risk assessment index (RAI) in discriminating between benign and malignant ovarian tumors.
    Begum FD; Høgdall E; Kjaer SK; Blaakaer J; Christensen IJ; Christensen L; Høgdall C
    Gynecol Oncol; 2009 May; 113(2):221-7. PubMed ID: 19261323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 28 day post-operative persisted hypercoagulability after surgery for benign diseases: a prospective cohort study.
    Ulrych J; Kvasnicka T; Fryba V; Komarc M; Malikova I; Burget F; Brzezkova R; Kvasnicka J; Krska Z; Kvasnicka J
    BMC Surg; 2016 Apr; 16():16. PubMed ID: 27048604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The estimation of the probability of tumor malignacy on the basis of test combination in the primary diagnosis of adnexal tumors].
    Smoleń A; Stachowicz N; Czekierowski A; Kotarski J
    Ginekol Pol; 2010 Apr; 81(4):254-61. PubMed ID: 20476596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.